Functional Gastrointestinal Disorders.

[1]  A. Ford,et al.  British Society of Gastroenterology guidelines on the management of functional dyspepsia , 2022, Gut.

[2]  A. Lembo,et al.  AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Diarrhea. , 2022, Gastroenterology.

[3]  S. Shoaie,et al.  Irritable bowel syndrome and microbiome; Switching from conventional diagnosis and therapies to personalized interventions , 2022, Journal of translational medicine.

[4]  M. Cicala,et al.  Diarrhea Predominant-Irritable Bowel Syndrome (IBS-D): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms , 2021, Nutrients.

[5]  A. Fikree,et al.  Management of functional gastrointestinal disorders. , 2021, Clinical medicine.

[6]  W. Chey,et al.  ACG Clinical Guideline: Management of Irritable Bowel Syndrome. , 2020, The American journal of gastroenterology.

[7]  G. Barbara,et al.  Non-Celiac Gluten Sensitivity in the Context of Functional Gastrointestinal Disorders , 2020, Nutrients.

[8]  D. Drossman,et al.  Functional gastrointestinal disorders: advances in understanding and management , 2020, The Lancet.

[9]  P. Whorwell,et al.  Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. , 2020, Gastroenterology.

[10]  W. Whitehead,et al.  Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom. , 2020, Gastroenterology.

[11]  N. Talley.  What Causes Functional Gastrointestinal Disorders? A Proposed Disease Model. , 2020, The American journal of gastroenterology.

[12]  D. Drossman,et al.  Improving Patient-Provider Relationships to Improve Health Care. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[13]  J. Langhorst,et al.  Stress and the brain-gut axis in functional and chronic-inflammatory gastrointestinal diseases: A transdisciplinary challenge , 2019, Psychoneuroendocrinology.

[14]  Johannah Ruddy.  From Pretending to Truly Being OK: A Journey From Illness to Health With Postinfection Irritable Bowel Syndrome: The Patient's Perspective. , 2018, Gastroenterology.

[15]  P. Dupont,et al.  Understanding Neurogastroenterology From Neuroimaging Perspective: A Comprehensive Review of Functional and Structural Brain Imaging in Functional Gastrointestinal Disorders , 2018, Journal of neurogastroenterology and motility.

[16]  J. Pandolfino,et al.  Best Practice Update: Incorporating Psychogastroenterology Into Management of Digestive Disorders. , 2018, Gastroenterology.

[17]  Lin Chang,et al.  FUNCTIONAL BOWEL DISORDERS , 2018, The American Journal of Gastroenterology.

[18]  A. Ford,et al.  General practitioners’ perceptions of irritable bowel syndrome: a Q-methodological study , 2018, Family practice.

[19]  M. Young,et al.  Carnettʼs Sign: An Easy Tool That Saves Unnecessary Expenses in the Evaluation of Chronic Abdominal Pain: 1402 , 2017 .

[20]  G. Latella,et al.  Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis , 2017, Nutrients.

[21]  P. Moayyedi,et al.  ACG and CAG Clinical Guideline: Management of Dyspepsia. , 2017, The American journal of gastroenterology.

[22]  R. Carson,et al.  Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea , 2017, Health and Quality of Life Outcomes.

[23]  H Preissl,et al.  Functional neuroimaging studies in functional dyspepsia patients: a systematic review , 2016, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[24]  D. Drossman.  Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV. , 2016, Gastroenterology.

[25]  B. Lacy,et al.  Variation in Care for Patients with Irritable Bowel Syndrome in the United States , 2016, PloS one.

[26]  G. Eslick,et al.  Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis , 2016, European Journal of Nutrition.

[27]  N. Chia,et al.  Relationship Between Microbiota of the Colonic Mucosa vs Feces and Symptoms, Colonic Transit, and Methane Production in Female Patients With Chronic Constipation. , 2016, Gastroenterology.

[28]  R. Sherwood,et al.  Fecal calprotectin in inflammatory bowel disease , 2016, Clinical and experimental gastroenterology.

[29]  L. Böhn,et al.  Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. , 2015, Gastroenterology.

[30]  Yvan Leanza,et al.  A Systematic Review of Patients’ Experiences in Communicating with Primary Care Physicians: Intercultural Encounters and a Balance between Vulnerability and Integrity , 2015, PloS one.

[31]  M. Camilleri,et al.  Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis , 2015, Gut.

[32]  J. Bertrand,et al.  Quantification and Potential Functions of Endogenous Agonists of Transient Receptor Potential Channels in Patients With Irritable Bowel Syndrome. , 2015, Gastroenterology.

[33]  G. Barbara,et al.  Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome. , 2015, Gastroenterology.

[34]  M. Hastings,et al.  A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D) , 2015, Gut.

[35]  F. Bazzoli,et al.  Randomised controlled trial of mesalazine in IBS , 2014, Gut.

[36]  H. Tilg,et al.  Intestinal permeability – a new target for disease prevention and therapy , 2014, BMC Gastroenterology.

[37]  M. Surette,et al.  Tu1797 The Adoptive Transfer of Anxiety and Gut Dysfunction From IBS Patients to Axenic Mice Through Microbiota Transplantation , 2014 .

[38]  A. Ford,et al.  Prevalence of functional gastrointestinal disorders among consecutive new patient referrals to a gastroenterology clinic , 2014, Frontline Gastroenterology.

[39]  A. Rudensky,et al.  Metabolites produced by commensal bacteria promote peripheral regulatory T cell generation , 2013, Nature.

[40]  S. Vanner,et al.  Sensitization of Peripheral Sensory Nerves by Mediators From Colonic Biopsies of Diarrhea-Predominant Irritable Bowel Syndrome Patients: A Role for PAR2 , 2013, The American Journal of Gastroenterology.

[41]  P. Ducrotte,et al.  Luminal Cysteine-Proteases Degrade Colonic Tight Junction Structure and Are Responsible for Abdominal Pain in Constipation-Predominant IBS , 2013, American Journal of Gastroenterology.

[42]  R. Chapman,et al.  Randomized Clinical Trial: Macrogol/PEG 3350 Plus Electrolytes for Treatment of Patients With Constipation Associated With Irritable Bowel Syndrome , 2013, The American Journal of Gastroenterology.

[43]  P. Gibson,et al.  Drug-induced gastrointestinal disorders , 2013, Frontline Gastroenterology.

[44]  M. Dapoigny,et al.  The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota , 2013, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[45]  J. Tack,et al.  Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia , 2013, Gut.

[46]  W. Whitehead,et al.  Psychological treatments in functional gastrointestinal disorders: a primer for the gastroenterologist. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[47]  M. Currie,et al.  A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation , 2012, The American Journal of Gastroenterology.

[48]  F. Azpiroz,et al.  Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier , 2012, Gut.

[49]  J. Andrews,et al.  Sensory neuro-immune interactions differ between Irritable Bowel Syndrome subtypes , 2012, Gut.

[50]  S. Lecleire,et al.  The Expression and the Cellular Distribution of the Tight Junction Proteins Are Altered in Irritable Bowel Syndrome Patients With Differences According to the Disease Subtype , 2011, The American Journal of Gastroenterology.

[51]  Sebastian Tims,et al.  Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. , 2011, Gastroenterology.

[52]  G. Barbara,et al.  The Immune System in Irritable Bowel Syndrome , 2011, Journal of neurogastroenterology and motility.

[53]  M. Simrén,et al.  Physical Activity Improves Symptoms in Irritable Bowel Syndrome: A Randomized Controlled Trial , 2011, The American Journal of Gastroenterology.

[54]  S. Lecleire,et al.  Increased Proteasome-Mediated Degradation of Occludin in Irritable Bowel Syndrome , 2010, The American Journal of Gastroenterology.

[55]  R. Langer,et al.  Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. , 2009, Gastroenterology.

[56]  T. Wittmann,et al.  Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice , 2009, PAIN®.

[57]  D. Drossman,et al.  A Focus Group Assessment of Patient Perspectives on Irritable Bowel Syndrome and Illness Severity , 2009, Digestive Diseases and Sciences.

[58]  W. Chey,et al.  Clinical trial: lubiprostone in patients with constipation‐associated irritable bowel syndrome – results of two randomized, placebo‐controlled studies , 2009, Alimentary pharmacology & therapeutics.

[59]  W. Chey,et al.  An Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome , 2008, The American Journal of Gastroenterology.

[60]  P. Moayyedi,et al.  The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review , 2008, Gut.

[61]  J. Galmiche,et al.  Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators , 2008, Gut.

[62]  P. Gibson,et al.  Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[63]  K. Verbeke,et al.  Relationship between symptoms and ingestion of a meal in functional dyspepsia , 2008, Gut.

[64]  J. Corander,et al.  The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. , 2007, Gastroenterology.

[65]  D. Santini,et al.  Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. , 2004, Gastroenterology.

[66]  Alisha Ali,et al.  Emotional Abuse, Self-Blame, and Self-Silencing in Women With Irritable Bowel Syndrome , 2000, Psychosomatic medicine.

[67]  K W Heaton,et al.  Functional bowel disorders and functional abdominal pain , 1999, Gut.

[68]  D. Drossman,et al.  The functional gastrointestinal disorders and the Rome II process , 1999, Gut.

[69]  D. Drossman,et al.  The irritable bowel syndrome: review and a graduated multicomponent treatment approach. , 1992, Annals of internal medicine.

[70]  G. Sturniolo,et al.  [Irritable bowel syndrome]. , 1988, Giornale di clinica medica.

[71]  W. Whitehead,et al.  The Prevalence and Impact of Overlapping Rome IV-Diagnosed Functional Gastrointestinal Disorders on Somatization, Quality of Life, and Healthcare Utilization: A Cross-Sectional General Population Study in Three Countries , 2018, The American Journal of Gastroenterology.

[72]  M. F. Brian E. Lacy PhD,et al.  Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-analysis , 2018, The American Journal of Gastroenterology.

[73]  N. Talley,et al.  Functional dyspepsia. , 2017, Australian prescriber.

[74]  Gurkirpal Singh,et al.  Diagnosis, comorbidities, and management of irritable bowel syndrome in patients in a large health maintenance organization. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[75]  G. Barbara,et al.  Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. , 2007, Gastroenterology.